1. Home
  2. INDP vs SSKN Comparison

INDP vs SSKN Comparison

Compare INDP & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • SSKN
  • Stock Information
  • Founded
  • INDP 2000
  • SSKN 1989
  • Country
  • INDP United States
  • SSKN United States
  • Employees
  • INDP N/A
  • SSKN N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • SSKN Medical/Dental Instruments
  • Sector
  • INDP Health Care
  • SSKN Health Care
  • Exchange
  • INDP Nasdaq
  • SSKN Nasdaq
  • Market Cap
  • INDP 15.4M
  • SSKN 14.5M
  • IPO Year
  • INDP N/A
  • SSKN 2005
  • Fundamental
  • Price
  • INDP $1.11
  • SSKN $2.59
  • Analyst Decision
  • INDP Strong Buy
  • SSKN
  • Analyst Count
  • INDP 1
  • SSKN 0
  • Target Price
  • INDP $12.00
  • SSKN N/A
  • AVG Volume (30 Days)
  • INDP 20.2K
  • SSKN 12.6K
  • Earning Date
  • INDP 11-04-2024
  • SSKN 11-12-2024
  • Dividend Yield
  • INDP N/A
  • SSKN N/A
  • EPS Growth
  • INDP N/A
  • SSKN N/A
  • EPS
  • INDP N/A
  • SSKN N/A
  • Revenue
  • INDP N/A
  • SSKN $32,729,999.00
  • Revenue This Year
  • INDP N/A
  • SSKN N/A
  • Revenue Next Year
  • INDP N/A
  • SSKN $8.71
  • P/E Ratio
  • INDP N/A
  • SSKN N/A
  • Revenue Growth
  • INDP N/A
  • SSKN N/A
  • 52 Week Low
  • INDP $1.03
  • SSKN $2.51
  • 52 Week High
  • INDP $3.25
  • SSKN $7.10
  • Technical
  • Relative Strength Index (RSI)
  • INDP 34.05
  • SSKN 36.95
  • Support Level
  • INDP $1.10
  • SSKN $2.57
  • Resistance Level
  • INDP $1.22
  • SSKN $2.88
  • Average True Range (ATR)
  • INDP 0.12
  • SSKN 0.21
  • MACD
  • INDP 0.00
  • SSKN -0.04
  • Stochastic Oscillator
  • INDP 16.20
  • SSKN 3.17

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United states.

Share on Social Networks: